The mission of the SAFE-IPS facility is to provide technological and scientific support to all the teams using induce pluripotent stem cells .

• Culture of primary cells : PBMC or MSC
  We can purify, amplify, freeze and bank primary cells and iPS stem cells
• Reprogramming : The core facility has already reprogrammed many cell lines from PBMC or fibroblasts.
• Differentiation : The core facility can assist users for the implementation of several differentiation protocols (spontaneous differentiation, directed differentiation).
• Training : The SAFE-IPS offers training for all the technique used, on demand. Do not hesitate to contact us for tailored training.
• Clinical application : A whole new facility dedicated to GMP iPSC production (MTI-PP) will be available in September 2023

Contact :

Romain Desprat,  PhD ; Responsable opérationnel plateforme SAFE-iPS
Institute for Regenerative Medecine & Biotherapy (IRMB) Hôpital Saint Eloi-CHU Montpellier; 80 avenue Augustin Fliche; 34295 Montpellier Cedex 05; Tel:  04 67 33 26 41 / 06 60 94 09 96 ; e-mail : r-desprat@chu-montpellier.fr / romain.desprat@inserm.fr